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Abstract
Background:  Visceral  Adiposity  Index  (VAI)  has  been  strongly  associated  with  adipocy-
tokine synthesis,  proinﬂammatory  activity,  insulin  resistance,  dyslipidemia,  hypertension  and
atherosclerosis.  VAI  is  a  model  that  includes  and  correlates  anthropometric  and  metabolic  mark-
ers and  has  been  proposed  as  a  risk  factor  index  associated  with  cardiovascular  risk  in  adults.
Some studies  conducted  in  pediatric  population  have  extrapolated  VAI  calculation  in  order  to
predict these  abnormalities;  nonetheless,  no  adjustment  has  been  done  for  pediatric  ranges
in any  of  the  variables  included  in  the  formula.  The  aim  of  this  study  was  to  design  a  new
sex-speciﬁc  VAI  model  adjusted  for  pediatric  population.
Subjects  and  methods:  Cross-sectional  study,  548  children  (290  males  and  258  females)  aged
3-17 years  were  included  for  analysis.  Eutrophic,  apparently  healthy  children  (n  =  223)  were
recruited from  3  public  schools  located  nearby  the  hospital.  Overweight  (n  =  89)  and  obese  sub-
jects (n  =  236)  were  patients  that  regularly  attend  at  the  Pediatric  Obesity  Clinic  from  ‘‘Hospital
General de  México’’.  Anthropometric  evaluation  included  weight,  height,  waist  circumference
(WC). Body  mass  index  (BMI)  was  calculated  and  Tg  and  HDL  measured  in  a  12  hour  fasting
condition  (mMol/L).
Results:  A  non-lineal  quadratic  regression  model  accurately  explained  the  relationship  between
WC and  BMI  in  pediatric  population  (coefﬁcient  of  determination  R2 =  0.938;  p  <  0.001  for  males
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and  R2 =  0.907;  p  <  0.001  for  females).  Medians  of  triglycerides  and  HDL-cholesterol  values  of
223 healthy  children  were  used  to  calculate  the  second  formula  component  (Males:  median
Tg =  0.76  mmol/l,  median  HDL-cholesterol  =  1.37  mmol/l;  Females:  median  Tg  =  0.91  mml/l,
median  HDL-chloesterol  =  1.42  mmol/l).
Conclusions:  VAI  formula  construction  seemed  to  be  different  in  children  compared  to  adults.  In
the present  study  we  propose  a  new  gender-speciﬁc  visceral  adipose  index  for  pediatric  Mexican
population  living  in  urban  areas  that  could  be  further  used  to  predict  abnormal  cardiometabolic
outcomes.
© 2014  Sociedad  Médica  del  Hospital  General  de  México.  Published  by  Masson  Doyma  México
S.A. All  rights  reserved.
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Resumen
Introducción:  El  Indice  de  Adiposidad  Visceral  (IAV)  ha  sido  fuertemente  asociado  con  síntesis  de
adipocitocinas,  actividad  proinﬂamatoria,  resistencia  a  la  insulina,  dislipidemia,  hipertensión
y aterosclerosis.  El  IAV  es  un  modelo  que  incluye  y  correlaciona  marcadores  antropométri-
cos y  metabólicos  y  ha  sido  propuesto  como  un  índice  de  riesgo  cardiovascular  en  adultos.
Algunos estudios  realizados  en  población  pediátrica  han  extrapolado  el  cálculo  del  IAV  con  el
ﬁn de  predecir  estas  anormalidades  en  nin˜os;  sin  embargo,  no  se  han  hecho  ajustes  para  rangos
pediátricos  en  ninguna  de  las  variables  incluidas  en  la  fórmula.  El  objetivo  de  este  estudio  fue
disen˜ar un  nuevo  IAV  género-especíﬁco  ajustado  para  población  pediátrica.
Sujetos  y  métodos: Estudio  transversal,  se  incluyeron  un  total  de  548  pacientes  pediátricos
(290 varones,  258  mujeres)  entre  3-17  an˜os  de  edad.  Nin˜os  eutróﬁcos,  aparentemente  sanos
(n =  223)  fueron  reclutados  de  3  escuelas  públicas  localizadas  en  la  periferia  del  hospital.  Sujetos
con sobrepeso  y  obesos  (n  =  89  y  n  =  236,  respectivamente)  fueron  pacientes  atendidos  regular-
mente en  la  Clínica  de  Obesidad  Pediátrica  del  Hospital  General  de  México.  La  evaluación
antropométrica  incluyó  peso,  talla,  circunferencia  de  cintura  (CC).  Se  calculó  el  índice  de
masa corporal  (IMC)  y  se  midieron  Tg  y  HDL-colesterol  en  una  condición  de  12  horas  de  ayuno
(mMol/L).
Resultados:  Un  modelo  de  regresión  no-lineal  cuadrática  explicó  con  mayor  exactitud  la
relación entre  CC  e  IMC  en  población  pediátrica  (coeﬁciente  de  determinación  R2 =  0.938;
p <  0.001  para  hombres  y  R2 =  0.907;  p  <  0.001  para  mujeres).  La  mediana  de  triglicéridos  y
HDL-colesterol  de  223  nin˜os  sanos  se  emplearon  para  calcular  el  segundo  componente  de  la
fórmula (Hombres:  mediana  Tg  =  0.76  mmol/l,  mediana  HDL-colesterol  =  1.37  mmol/l;  Mujeres:
mediana Tg  =  0.91  mml/l,  mediana  HDL-colesterol  =  1.42  mmol/l).
Conclusiones:  la  construcción  de  la  fórmula  del  IAV  parece  ser  diferente  en  nin˜os  comparado  con
adultos. En  este  estudio,  proponemos  un  nuevo  IAV  género-especíﬁco  para  población  pediátrica
mexicana  que  reside  en  áreas  urbanas,  que  podría  además  ser  usado  para  predecir  alteraciones
cardiometabólicas.
© 2014  Sociedad  Médica  del  Hospital  General  de  México.  Publicado  por  Masson  Doyma  México
S.A. Todos  los  derechos  reservados.
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besity  has  emerged  as  a  highly  prevalent  chronic  disease  in
hildren,  particularly  in  those  living  in  developing  countries.
verweight  and  obesity  prevalence  in  Mexican  pediatric
opulation  between  5  and  11  years  of  age  increased
p  to  37%  throughout  2006-2012,  according  to  ENSANUT
0121.  Obesity  but  mainly  visceral  adiposity  increases  the
isk  of  having  type  2  diabetes  (T2D),  insulin  resistance,
yslipidemia,  cardiovascular  diseases  and  non-alcoholic
m
i
i
pteatohepatitis.  Dysfunctional  visceral  adipose  deposition
as  been  described  as  a  morbidity  and  mortality  risk  factor
ven  in  normal  weight  subjects.  More  than  two  thirds  of
hildren  10  years  and  older  who  are  obese  will  become
bese  adults2.  Obesity  in  young  adults  decreases  life
xpectancy  by  5-20  years  and  confers  long-term  effects  on
orbidity3,4. It  is  imperative  to  design  effective  and  useful
n  clinical  setting  tools  to  detect  early  metabolic  abnormal-
ties,  in  order  to  promote  early  optimal  intervention  and
revent  cardiovascular  and  metabolic  diseases  in  children
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and  young  adults.  Metabolic  syndrome  (MS)  components
are  a  cluster  of  metabolic  and  cardiovascular  abnormalities
that  are  relatively  stable,  tend  to  track  from  childhood
to  adulthood  and  are  mainly  consequences  of  insulin
resistance.  No  speciﬁc  cut-off  points  of  these  abnormalities
have  been  standardized  for  pediatric  population5 and  few
data  regarding  consequences  along  life  span  have  been  pub-
lished.  Most  of  the  MS  deﬁnitions  in  this  age  group  consider
abdominal  obesity  as  a  the  key  cornerstone  of  metabolic
derangement  since  adipose  tissue  modulates  metabolism
by  releasing  NEFAs  (Non-esteriﬁed  fatty  acids)  and  glyc-
erol,  hormones  (leptin,  adiponectin),  and  proinﬂamatory
cytokines6.
Visceral  Adiposity  Index  (VAI),  a  gender-speciﬁc  mathe-
matical  index  based  on  simple  anthropometric  (BMI  and  WC)
and  metabolic  parameters  (TG  and  HDL),  has  been  proposed
by  Amato  el  al7 as  a  surrogate  marker  of  adipose  tissue  func-
tion  and  distribution.  VAI  has  shown  to  be  independently
associated  to  cardiovascular  and  cerebrovascular  events,
and  inversely  related  to  insulin  sensitivity.  By  contrast,  these
authors  found  no  correlations  for  these  outcomes  when
WC  or  BMI  were  compared  independently.  Similar  data  has
been  reported  by  other  authors  regarding  several  conditions
related  to  insulin  resistance  and  cardiometabolic  risk8,9.  A
protocol  conducted  in  pediatric  population  has  extrapolated
VAI  calculation  to  eutrophic  and  obese  children  in  order
to  predict  insulin  resistance  and  subclinical  inﬂammation10.
This  study  failed  to  demonstrate  VAI  superiority  over  BMI  or
WC.  However,  no  adjustment  was  done  for  pediatric  ranges
in  any  of  the  variables  included  in  the  formula.  In  fact,  this
correction  seems  to  be  suitable  since  visceral  adipose  depo-
sition,  absolute  values  of  BMI,  WC-BMI  correlation,  as  well
as  triglyceride  and  HDL-cholesterol  levels  might  be  different
for  pediatric  population.
The  aim  of  the  present  study  was  to  design  a  new  gender-
speciﬁc  VAI  model  adjusted  for  pediatric  population  and
based  on  the  original  VAI  formulation  for  adults.
Material and methods
Subjects
Eutrophic,  overweight  and  obese  girls  and  boys  between  3
and  17  years  of  age  were  included  in  the  study.  Eutrophic  and
otherwise  healthy  individuals  were  recruited  from  3  Public
Schools  nearby  the  Hospital  General  de  Mexico.  An  informed
consent  and  assent  (Both  approved  from  the  IRBs)  were
obtained  from  parents  and  children  respectively.  Data  from
overweight  and  obese  subjects  were  recorded  anonymously
out  of  the  database  of  the  patients  that  regularly  attend
pediatric  obesity  clinic  at  Hospital  General  de  México,  so
no  individual  informed  consent  was  needed  for  this  group  of
patients.  Obesity  was  deﬁned  when  BMI  (deﬁned  as  weight
in  kilograms  divided  by  the  square  of  height  in  meters)  ≥
95th  Pc,  overweight  ≥  85th  Pc  and  <95th  Pc  and  normal
weight  if  BMI  ≥25th  Pc  and  <  85thPc  according  to  CDC  deﬁni-
tions.  Exclusion  criteria  considered  endogenous,  endocrine
or  genetic  obesity,  T2D,  systemic  illness,  or  administration  of
medications  that  interfere  with  glucose  or  lipid  metabolism.
Psychiatric  conditions  and  disordered  eating  behavior  were
also  excluded.
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hysical  examination
xamination  was  carried  out  by  trained  pediatricians,
ediatric  endocrinologists  and  nutritionists  previously  stan-
ardized.  Body  weight  was  measured  in  light  clothing  and
arefoot  with  a  mechanical  column  scale  (to  0.1  kg)  and
tanding  height  with  a  standard  stadiometer  board  mounted
n  the  wall  (to  the  nearest  0.1  cm).  WC  was  measured  at  the
idpoint  between  the  lowest  rib  and  the  immediately  above
oint  of  the  iliac  crest,  using  a  non-stretchable  standardized
berglass  tape  and  at  the  end  of  exhalation.  Blood  pres-
ure  was  measured  with  a  sphyngmomanometer.  The  blood
ressure  cuff  had  bladders  long  enough  to  encircle  at  least
ne-half  of  the  upper  arm  without  overlapping  and  widths
hat  covered  at  least  two-thirds  of  the  upper  arm.  Complete
hysical  examination  was  done  in  order  to  detect  associated
omorbidities.
iochemical  markers
lood  samples  were  obtained  after  12  hour  fasting  and  total
holesterol,  high-density  lipoprotein  (HDL-cholesterol),
ow-density  lipoprotein  cholesterol  (LDL-cholesterol)  and  Tg
etermined  at  the  Hospital  General  de  Mexico’s  Laboratory.
he  methodology  used  to  analyze  blood  samples  was  the
ollowing:  the  reactant  HDLD  with  the  SYNCHRON  Systems
alibrator  was  used  for  lipids  determination;  SYNCHRON  LX
ystem  and  the  UniCel  DxC  600/800  system  were  used  for
uantitative  measurement  of  the  HDL-Cholesterol  values  on
uman  plasma.  This  methodology  does  not  require  a  sample
retreatment.
The  GPO  (Glycerol  Phosphate  oxidase)  reactant,  SYN-
HRON  System  Multi  Calibrator,  the  Triglycerides  GPO
arameters,  the  SYNCHRON  LX  system  and  the  DxC  600/800
nicel  DxC  system,  were  used  to  determine  the  quantitative
oncentration  of  triglycerides  on  human  plasma.  The  volume
equired  was  0.3  ml  of  blood  sample.  The  GPO  reactant  was
sed  to  evaluate  the  triglycerides  concentration  with  an  end
oint  method  on  a  determinate  time.
ndex  calculation
riginal  VAI  index  was  constructed  by  two  independent  com-
onents.  The  ﬁrst  one  represents  a  correlation  between
C  and  BMI.  In  our  study,  we  decided  to  include  the  over-
ll  sample  of  normal  weight  otherwise  healthy,  overweight
nd  obese  children  in  order  to  model  the  complete  equa-
ion  throughout  the  BMI  spectrum.  The  second  one,  was  to
ntroduce  to  the  formula  the  fat  function.  Tg  and  and  HDL-
holesterol  medians  of  healthy  individuals  were  calculated.
ased  on  the  original  adult  formula,  visceral  adipose  dys-
unction  was  arbitrarily  set  for  Triglycerides  values  higher
han  median  values  of  healthy  population  and  HDL  values
ower  than  the  median  values  of  healthy  population.
tatistical  analysisnivariate  analysis  was  conducted  and  results  are  presented
s  frequency,  mean  and  standard  deviation  of  demo-
raphic  median,  anthropometric  measures  and  metabolic
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yndrome  components.  Common  logarithm  base-10  trans-
ormation  was  used  for  non-normal  distributed  variables.
ineal  correlation  between  anthropometric  variables  waist
ircumference  and  Body  Mass  Index  was  tested  with  Product-
oment  Pearson  coefﬁcient,  however,  the  residual  analysis
uggested  a  non-linear  correlation.  A  quadratic  mathemat-
cal  model  by  gender  was  the  best  approach  using  ordinal
east  squares  for  data  ﬁtness,  and  was  used  for  regression
nalysis  between  WC  and  BMI  to  calculate  the  ﬁrst  VAI  for-
ula  component.  The  percentage  of  covariation  (size  of
ffect)  was  calculated  using  the  coefﬁcient  of  determination
R2)  and  a  p-value  less  than  0.05  was  considered  as  statis-
ical  signiﬁcant.  The  Statistical  Package  for  Social  Sciences
oftware  (SPSS  220;  Chicago  IL)  was  used  for  the  analysis.
thics
he  study  protocol  was  approved  by  the  Ethics  and  Research
nstitutional  Review  Boards  and  Informed  consent  and  assent
ere  obtained  from  parents  and  children  respectively.
he  study  follow  the  NOM-012-SSA3-2012  and  according  to
he  ICH  Harmonized  Tripartite  Guideline  for  Good  Clinical
ractice  E6R1.
esults
 total  of  548  children  (290  males  and  258  females)  mean
ge  10.7  ±  5.52:  range  3-17  years  old  were  included  for
he  analysis.  Variables  of  interest  are  shown  in  Table  1.
utrophic  children  (119  males  and  104  females)  were
onsidered  as  reference  to  calculate  formula  components
eparately  for  each  gender.  Three  hundred  and  twenty  ﬁve
verweight  and  obese  children  (171  males  and  154  females)
nd  eutrophics  were  considered  to  calculate  WC-BMI
orrelation.  A  wide  spectrum  of  BMI  categories  (eutrophic,
verweight  and  obese  individuals)  were  considered  to
esign  the  mathematical  regression  model  that  was  used  to
orrelate  WC  and  BMI  variables  (coefﬁcient  of  determina-
ion  R2 =  0.938;  p  <  0.001  for  males  and  R2 =  0.907;  p  <  0.001
or  females  ﬁg.  1A  and  1B),  in  order  to  calculate  the  ﬁrst
AI  formula  component.  A  non-lineal  quadratic  regression
k
s
t
a
Table  1  Demographic  and  biochemical  variables  by  weight  and  s
Normal  Weight  
Variables  of  interest* Males  n  =  119  Fem
Age  (years)  9.3  ±  1.78  9
Weight (kg)  30.16  ±  6.88  30
Height (cm)  133.52  ±  10.8  133
BMI (kg/m2)  16.67  ±  1.60  16
WC (cm)  58.56  ±  5.49  58
Syst Blood  Pressure  (mm/Hg)  88.68  ±  7.37  88
Diast Blood  Pressure  (mm/Hg)  55.57  ±  7.42  56
Triglycerides  (mmol/L)  0.86  ±  0.38  0
HDL-Cholesterol  (mmol/L)  1.39  ±  0.34  1
BMI -Body Mass Index, WC - Waist Circumference, Syst Blood Pressure 
Pressure, HDL-Cholesterol -- High Density Lipoprotein Cholesterol.
Data show mean ± SD.
* All comparisons between Normal weight Vs Overweight/Obesity groM.J.  Garcés  et  al.
odel  instead  of  a  lineal  correlation  (described  for  adult
opulation)  accurately  explained  the  relationship  between
aist  circumference  and  BMI  in  boys  (F-ratio  =  1.05,  p  <  0.05)
nd  in  girls  (F-ratio  =  1.04,  p  <  0.05).
Medians  of  TG  and  HDL  values  of  the  223  healthy
hildren  were  used  to  calculate  the  second  formula
omponent  (Males:  median  TG  =  0.76  mmol/l,  median
DL  =  1.37  mmol/l;  Females:  median  TG  =  0.91  mml/l,
edian  HDL  =  1.42  mmol/l).  The  obtained  formulas  for  boys
nd  girls  were  deﬁned  as  follows:
ales  VAI  = WC−0.023  BMI2 +  3.83  BMI  +  0.65
[
Tg
0.76
] [
1.37
HDL
]
emales  VAI  = WC−0.018  BMI2 +  3.30  BMI  +  7.86
[
Tg
0.91
] [
1.42
HDL
]
iscussion
his  study  supports  a  novel  index  of  cardiometabolic  risk
alculated  by  each  gender.  The  method  includes  a  sample
f  eutrophic  Mexican  population  as  reference  of  risk  times
s  an  omnibus  variable.
Central  obesity  is  mainly  related  to  visceral  fat  accu-
ulation.  Both,  subcutaneous  and  visceral  fat  had  been
tudied  as  independent  compartments  and  associated  to
ardiometabolic  comorbidities11.  Acquisition  of  visceral  fat
uring  childhood  and  adolescence  has  been  positively  cor-
elated  to  Total  Cholesterol,  LDL-Cholesterol,  Triglycerides,
yperinsulinemia,  and  inversely  to  insulin  sensitivity  and
DL-Cholesterol  levels12,13. Changes  in  adipose  tissue  envi-
onment  and  behavior  is  a result  of  adipocyte  hypertrophy,
ypoxia,  decreased  adiponectin  production,  increased  TNF-
,  IL-6  and  several  other  adipocytokines  levels,  and  is
nown  as  ‘‘adipose  tissue  dysfunction’’14.  VAI  has  been
trongly  associated  to  adipocytokine  synthesis,  proinﬂama-
ory  activity,  insulin  resistance,  dyslipidemia,  hypertension
nd  atherosclerosis8,9.  VAI  has  been  described  by  Amato  as
ex.
Overweight/Obesity
ales  n  =  104  Males  n  =  171  Females  n  =  154
.32  ±  1.89  11.82  ±  9.05  11.55  ±  3.74
.60  ±  8.51  61.60  ±  23.63  61.53  ±  24.06
.48  ±  13.59  147.12  ±  17.49  144.90  ±  17.98
.81  ±  1.81  26.95  ±  4.97  27.94  ±  5.83
.60  ±  5.97  86.79  ±  14.16  85.97  ±  14.79
.54  ±  8.43  106.32  ±  14.73  105.95  ±  14.00
.39  ±  7.04  68.98  ±  8.69  68.44  ±  10.68
.97  ±  0.41  1.75  ±  1.08  1.67  ±  0.96
.35  ±  0.32  0.97  ±  0.23  0.96  ±  0.24
-- Systolic Blood Pressure, Diast Blood Pressure -- Diastolic Blood
uped by females and males were p < 0.001.
Visceral  adiposity  index  in  pediatrics  157
289 Males
cc
R2=0.938 R2=0.907
IMC
10.00
40.00
60.00
80.00
100.00
120.00
WC
A B
140.00
20.00 30.00 40.00 50.00
IMC
10.00
40.00
60.00
80.00
100.00
120.00
WC
140.00
20.00 30.00 40.00 50.00
cc
259 Females
WC= –0.023 BMI 2 + 3.83 BMI + 0.65 WC= –0.018 BMI 2 + 3.30 BMI + 7.86
Figure  1  A  quadratic,  non-lineal  regression  model  explained  the  Correlation  between  WC  and  BMI.
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VR2 =  0.938;  p  <  0.001).  1B  Correlation  for  females  (coefﬁcient  of
a  need  to  understand  and  describe  adiposity  not  only  as  a
relationship  between  weight  and  height  (BMI  suggested  by
Quetelet),  but  as  a  matter  of  fat  location  and  function.  As
visceral  fat  drains  directly  into  the  portal  circulation,  it  has
been  linked  to  many  of  the  comorbidities  associated  with
obesity15.  There  are  only  few  clinical  tools  to  deﬁne  this
central  adiposity.  WC  has  been  considered  as  the  most  valid
measure  of  regional  location  of  adipose  tissue  and  strongly
related  to  visceral  fat  and  abdominal  adiposity16.  It  has  been
used  as  an  instrument  to  detect  high  risk  patients,  as  it  is  an
independent  predictor  of  insulin  resistance,  lipid  levels,  and
hypertension17.  Nonetheless,  a  controversial  limitation  of
WC  is  its  inability  to  make  distinction  between  subcutaneous
and  visceral  fat  within  the  abdominal  segment.  Although  BMI
has  been  routinely  used  to  classify  nutritional  status13,18 and
to  evaluate  cardiometabolic  risk  in  children  and  adults  from
an  epidemiology  viewpoint,  several  publications  have  sug-
gested  that  abdominal  obesity  makes  a  higher  contribution
than  BMI  to  the  probability  of  morbid  events19,20.  In  fact,
BMI  did  not  appeared  as  a  strong  predictor  for  coronary  and
cardiovascular  disease  in  the  Framingham  study.  Further-
more,  waist-to-height  ratio  (WHtR)  has  been  tested  as  well
as  a  surrogate  index  of  visceral  adiposity  and  cardiovascular
risk  in  adults  and  children21.  Some  meta-analysis  conducted
in  adult  population  demonstrated  that  WHtR  is  superior  to
BMI  in  detecting  several  cardiometabolic  risk  factors22 and,
particularly,  T2D23.  WC  seemed  to  be  a  reliable  marker  of
adipose  tissue  distribution,  nonetheless  a  recent  study  pub-
lished  by  Goodwin  et  al24,  suggests  that  particularly  among
adolescents,  routine  clinical  measurements  such  as  BMI  and
WC  might  predict  well  subcutaneous  but  not  visceral  fat
when  compared  to  body  fat  distribution  measured  by  Mag-
netic  Resonance  Imaging.  Moreover,  even  though  visceral
fat  accumulation  could  be  reliably  predicted  by  WC  mea-
surements,  controversy  has  emerged  since  some  authors
had  described  healthy  metabolic  but  obese  phenotype  in
the  general  population25--27.  Large-scale  genomewide  studies
S
d
l
prmination  R2  =  0.907;  p  <  0.001).
ave  recently  pointed  out  that  obesity  related  comorbidi-
ies  might  be  a  consequence  of  variations  in  genes  encoding
roteins  that  regulate  pathway  signals  involved  in  adipogen-
sis,  adipocyte  differentiation,  adipose  tissue  expandability
nd  distribution  as  well  as  ectopic  fat  dysfunction.  Kilpeläi-
en  et  al.  described  that  body-fat--decreasing  allele  near
RS1  is  associated  with  decreased  IRS1  expression  and  with
n  impaired  metabolic  proﬁle,  including  increased  visceral
o  subcutaneous  fat  ratio,  insulin  resistance,  dyslipidemia,
isk  of  T2D  and  coronary  artery  disease  and  decreased
diponectin  levels28.  As  large  scale  genomewide  studies
ontinue  to  be  identiﬁed,  the  understanding  of  phenotypic
etabolic  variations  as  well  as  morbid  outcomes  among  nor-
al  weight  and  obese  individuals  will  be  clariﬁed.
Visceral  adipose  index  has  recently  proved  to  be  an
ndicator  of  adipose  tissue  distribution  and  dysfunction  as
t  has  been  proposed  as  a  reliable  risk  factor  of  cardio-
ascular  (OR  (95%CI):2.45  (1.52-3.95)  and  cerebrovascular
OR(95%CI):1.63(1.06-2.5)  events7. A  ROC  analysis  proved
n  this  study  a  greater  sensitivity  and  speciﬁcity  of  VAI  com-
ared  to  its  individual  components  (WC,  BMI,  Triglycerides
nd  HDL-cholesterol).  Moreover,  in  women  with  Polycystic
vary  Syndrome  VAI  has  been  used  to  distinguish  metabol-
cally  healthy  from  metabolically  unhealthy  cases29,30. Oh
t  al.  reported  in  Korean  population  that  VAI  positively  cor-
elated  with  Visceral  Fat  Area,  the  visceral-to-subcutaneous
at  ratio,  and  systolic  and  diastolic  blood  pressure,  and  neg-
tively  with  the  Rd  value  after  euglycemic  hyperinsulinemic
lamp  in  young  women  with  polycystic  ovary  syndrome31.
ang  et  al  were  able  to  support  the  concept  that  arterial
tiffness,  measured  through  brachial-ankle  pulse  wave
elocity,  signiﬁcantly  increased  across  groups  with  higher
AI  levels  even  in  the  same  metabolic  category  (p  <  0.001)8.
everal  authors  have  proposed  VAI  as  a  marker  of  metabolic
isturbances  in  other  pathologies  such  as  non-alcoholic  fatty
iver  disease  and  non-alcoholic  steatohepatitis,  acromegaly,
rolactinoma,  and  Cushing  disease32. Few  studies  have
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258  
nalyzed  VAI  as  a  surrogate  cardiometabolic  risk  factor  in
ediatric  population.  Al-Daghri  et  al,  conducted  a  cross
ectional  study  in  Saudi  children  and  adolescents  and  results
re  inconsistent  with  previous  reports  generated  for  adult
opulation.  In  that  study  BMI  and  WC  showed  to  be  superior
n  terms  of  association  with  adipocytokines,  blood  pressure,
OMA-IR  and  CRP  levels  compared  to  VAI.  Interestingly,
AI  was  independently  associated  with  glucose  values.
onetheless,  our  study  had  proposed  a  novel  VAI  formula
riginated  from  a  pediatric  population  and  based  on  original
ormula  construction  that  seems  to  be  more  suitable  for  this
ge  group  since  visceral  adipose  deposition,  absolute  values
f  BMI,  WC-BMI  correlation,  as  well  as  triglycerides  and
DL-cholesterol  levels  differ  from  those  reported  for  adults.
e  should  be  then  cautious  while  interpreting  these  results.
Visceral  adipose  index  emerged  as  an  empirical-
athematical  model  originated  from  observations  in  normal
nd  overweight,  but  non  obese  adult  individuals  (19-83  year
ld).  A  linear  equation  was  extrapolated  to  correlate  WC  and
MI.  For  our  study  we  decided  to  include  normal  weight,
verweight  and  obese  children  in  order  to  map  out  the
verall  WC-BMI  spectrum.  A  non-lineal  quadratic  regres-
ion  model  instead  of  a  linear  correlation  explained  more
ccurately  the  relationship  between  WC  and  BMI  in  the
verall  sample.  Quadratic  tendency  of  the  equation  was
vident  while  BMI  increased  throughout  the  morbid  obese
ange  suggesting  a  tendency  of  WC  to  reach  a  steady  state
evel  afterwards.  This  complementary  segment  of  the  equa-
ion  was  not  evaluated  in  the  study  published  by  Amato
t  al,  since  they  did  not  include  obese  individuals  (BMI  ≥
0  kg/m2).  By  the  other  hand,  we  should  consider  childhood
s  a  dynamic  process  of  weight  and  height  gain  and  exag-
erated  abnormal  hyperplastic  adiposity  rebound  can  occur
n  prepubertal  children  exposed  to  an  obesigenic  milieu.  In
act,  VAI  formula  construction  seems  to  be  different  in  chil-
ren  compared  to  adults.  One  limitation  of  this  study  lies  in
ts  cross-sectional  design,  which  does  not  allow  for  obtaining
ut-off  points  in  order  to  identify  children  and  adolescents  at
isk  for  metabolic  and  cardiovascular  alterations.  However,
t  least  for  the  Mexican  population,  equation  proposed  in
his  study  may  potentially  be  used  for  both  clinical  and  epi-
emiological  applications  bearing  in  mind  that  they  must  be
alidated  against  other  prospective  studies.  Furthermore,
AI  could  be  a  useful  tool  during  intervention  and  follow-up
n  obese  and  non-obese  children  and  could  be  as  well  deﬁned
s  better  predictor  of  early  cardiovascular  and  metabolic
isk  in  all  borderline  conditions  in  which  overt  metabolic
yndrome  is  not  present32
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